160 related articles for article (PubMed ID: 34439877)
1.
Ha JH; Jayaraman M; Yan M; Dhanasekaran P; Isidoro C; Song YS; Dhanasekaran DN
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439877
[TBL] [Abstract][Full Text] [Related]
2. Suppression of GNAI2 message in ovarian cancer.
Raymond JR; Appleton KM; Pierce JY; Peterson YK
J Ovarian Res; 2014 Jan; 7():6. PubMed ID: 24423449
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
4. Identification of
Ha JH; Jayaraman M; Yan M; Dhanasekaran P; Isidoro C; Song YS; Dhanasekaran DN
Oncol Lett; 2021 Oct; 22(4):719. PubMed ID: 34429759
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product.
Ikezu T; Okamoto T; Murayama Y; Okamoto T; Homma Y; Ogata E; Nishimoto I
J Biol Chem; 1994 Dec; 269(50):31955-61. PubMed ID: 7989371
[TBL] [Abstract][Full Text] [Related]
6. GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS).
Yu H; Liu S; Wu Z; Gao F
Oxid Med Cell Longev; 2022; 2022():1254367. PubMed ID: 36275898
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
8. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
Ha JH; Yan M; Gomathinayagam R; Jayaraman M; Husain S; Liu J; Mukherjee P; Reddy EP; Song YS; Dhanasekaran DN
Oncotarget; 2016 Nov; 7(45):72845-72859. PubMed ID: 27655714
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
Peng X; Yu M; Chen J
J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
[TBL] [Abstract][Full Text] [Related]
12. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
13. Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.
Ha JH; Gomathinayagam R; Yan M; Jayaraman M; Ramesh R; Dhanasekaran DN
Genes Cancer; 2015 Jul; 6(7-8):356-364. PubMed ID: 26413218
[TBL] [Abstract][Full Text] [Related]
14. GNAI2 Promotes Proliferation and Decreases Apoptosis in Rabbit Melanocytes.
Hu S; Dai Y; Bai S; Zhao B; Wu X; Chen Y
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440304
[TBL] [Abstract][Full Text] [Related]
15. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
Wang H; Ye F; Zhou C; Cheng Q; Chen H
PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
[No Abstract] [Full Text] [Related]
17. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
[TBL] [Abstract][Full Text] [Related]
18. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
[TBL] [Abstract][Full Text] [Related]
19. [Expression of lysophosphatidic acid receptor in human ovarian cancer cell lines 3AO, SKOV3, OVCAR3 and its significance].
Wang P; Wu XH; Chen WX; Shan BE; Guo Q
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1422-4, 1431. PubMed ID: 16305971
[TBL] [Abstract][Full Text] [Related]
20. Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors.
Shen Y; Mamers P; Jobling T; Burger HG; Fuller PJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):4159-61. PubMed ID: 8923876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
